UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of October 2026 (Report No. 2)
Commission File Number: 001-40303
Qtrex
Quantum Ltd.
(Translation of registrant’s name into
English)
2 Ilan Ramon St.
Ness-Ziona 7403635, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
☒
Form 20-F ☐
Form 40-F
CONTENTS
On October 9, 2026, Qtrex
Quantum Ltd. (the “Company”) issued a press release titled “QTREX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement.” a copy of which is furnished as Exhibit 99.1 with this Report of Foreign Private Issuer on Form 6-K (this
“Report”).
This Report is incorporated
by reference into the Company’s Registration Statements on Form F-3 (Registration Nos. 333-284308, 333-289324 and 333-296482) and
Form S-8 (Registration Nos. 333-297590, 333-259057, 333-277980, 333-285565, 333-290162 and 333-292592), filed with the Securities
and Exchange Commission, to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents
or reports subsequently filed or furnished.
EXHIBIT INDEX
Exhibit
Number |
|
Description of Document |
| 99.1 |
|
Press release issued by Qtrex Quantum Ltd. on October 9, 2026, titled “QTREX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement.” |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
Qtrex Quantum Ltd. |
| |
|
|
| Date: October 9, 2026 |
By: |
/s/ Dagi Ben-Noon |
| |
|
Name: |
Dagi Ben-Noon |
| |
|
Title: |
Chief Executive Officer |
Exhibit 99.1
QTREX
Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement
Shares
back above $1.00 for 6 consecutive trading days
Ness Ziona, Israel, Oct. 09, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) (“QTREX” or the “Company”), a company focused
on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure, announced today that on October
5, 2026 it received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)
indicating that, for the 30 consecutive business days from August 20, 2026 through October 1, 2026, the closing bid price of the Company’s
ordinary shares had been below the minimum of $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq
Listing Rule 5550(a)(2).
The
notification has no immediate effect on the listing or trading of the Company’s ordinary shares, which continue to be listed and
traded on The Nasdaq Capital Market under the symbol “QTEX”. Since the end of the measurement period covered by the notification,
the closing bid price of the Company’s ordinary shares has been above $1.00 per share on each of the 6 consecutive business days
from October 2, 2026 through October 9, 2026.
In
accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days from the date of the notification,
or until April 3, 2027, to regain compliance with the minimum bid price requirement. If at any time during this period the closing bid
price of the Company’s ordinary shares is at least $1.00 per share for a minimum of 10 consecutive business days, Nasdaq will provide
the Company with written confirmation of compliance and the matter will be closed.
About
QTREX Quantum
QTREX
Quantum Ltd. (Nasdaq: QTEX) is a technology company focused on advanced connectivity and electronics manufacturing solutions for quantum
computing and other advanced hardware markets. Following its acquisition of the AME platform, the Company is developing high-density,
thermally optimized quantum connectivity solutions for dilution cryostats and advancing AME applications for defense, aerospace, missile,
space, and other mission-critical environments. The Company also continues to advance its medical technology portfolio, including respiratory
support and blood monitoring platforms, while actively working to monetize certain parts of the medical business.
For
more information, please visit: www.q-trex.com
Forward-Looking
Statement Disclaimer
This
press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking
statements are based on the current expectations of the management of the Company only and are subject to factors and uncertainties that
could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using
forward-looking statements when it discusses its anticipated share performance, its efforts to regain compliance with Nasdaq regulations,
and the timing and effects thereof. Except as otherwise required by law, the Company undertakes no obligation to publicly release any
revisions to these forward-looking statements. More detailed information about the risks and uncertainties affecting the Company is contained
under “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed
with the U.S. Securities and Exchange Commission.
Company
Contact
QTREX Quantum
Email: info@q-trex.com
Phone: +972-9-9664485
